Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  Vernalis plc    VER   GB00B3Y5L754

VERNALIS PLC (VER)

2
Delayed Quote. Delayed London Stock Exchange - 11/24 11:35:18 am
49.125 GBp   +2.34%
6d ago VERNALIS : Moves Year End To Align With US Cough Cold Season
6d ago VERNALIS : Change of Year End & Commercial Business Update
6d ago VERNALIS : Change of Year-End and Commercial Business Update
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
11/18/2014 11/19/2014 11/20/2014 11/21/2014 11/24/2014 Date
49.625(c) 50(c) 49.625(c) 48(c) 49.125(c) Last
571 354 53 462 51 307 2 258 834 37 476 Volume
-1.24% +0.76% -0.75% -3.27% +2.34% Change
More quotes
Company
Vernalis Plc is a research and development stage pharmaceutical company.The company provides pharmaceutical products for a range of medical disorders.It focuses on de novo fragment and structure based drug discovery and pre clinical and clinical development.The group has one marketed product,... 
Surperformance© rating of Vernalis plc
Trading Rating : Investor Rating :
More about the company
Chart VERNALIS PLC
Duration : Period :
Vernalis plc Technical Analysis Chart | VER | GB00B3Y5L754 | 4-Traders
Full-screen chart
Financials ( GBP)
Sales 2014 10,7 M
EBIT 2014 -11,7 M
Net income 2014 -10,3 M
Finance 2014 30,8 M
Yield 2014 -
Sales 2015 13,8 M
EBIT 2015 -17,0 M
Net income 2015 -15,5 M
Finance 2015 20,2 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 17,0x
EV / Sales 2015 13,9x
Capitalization 212 M
More Financials
Latest news on VERNALIS PLC
6d ago VERNALIS : Moves Year End To Align With US Cough Cold Season
6d ago VERNALIS : Change of Year End & Commercial Business Update
6d ago VERNALIS : Change of Year-End and Commercial Business Update
10/28 VERNALIS : Third Product in Vernalis’ Cough Cold Pipeline (CCP-08) Achieve..
10/28 VERNALIS : CTI BioPharma Corp. becomes Vernalis' worldwide licensee for tosedost..
10/27 VERNALIS : Makes CTI BioPharma Worldwide Licensee For Tosedostat
10/27 VERNALIS : CTI BioPharma Corp. becomes Vernalis’ worldwide licensee for to..
10/27 VERNALIS : Announces CTI Becomes Worldwide Licensee for Tosedostat
10/14 VERNALIS : Non-Executive Buys 103,000 Shares (DIRECTOR DEALINGS)
10/14 VERNALIS : Transactions of Directors
10/10 VERNALIS : Opens New Office In Pennsylvania, Bolsters US Management Team
10/10 VERNALIS : Opens US Office and Strengthens US Team With the Appointment of SVP M..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF